Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Erbe introduces VIO® 3n & VIO® seal: Tailored electrosurgical generators for high-performance workflows

Contributed by: Business Wire

Logo

Business Wire logo

Images

VIO 3n Fire
VIO 3n Fire
VIO 3n Water
VIO 3n Water
Business Wire embedded0

Tags

Other Manufacturing
Technology
Medical Devices
Surgery
Engineering
Health Technology
Software
Manufacturing
Hardware
Health
Erbe Elektromedizin GmbH

More Like This

New Erbe production and development building in Rangendingen, Germany (Photo: Business Wire)

Erbe Elektromedizin inaugurates new competence center for medical instruments in Rangendingen, Germany, and expands its capacities for customers all over the world

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

GlobeNewswire associated0

KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles

E&R Showcases Next-Gen Laser and Plasma Solutions with Strategic Partners at SEMICON SEA 2025 in Singapore

PR Newswire associated0

ECR 2025: Esaote Group presents Integrated Medical Imaging Solutions and unveils innovations in Ultrasound Technology

Butterfly iQ3 handheld point-of-care ultrasound device. (Photo: Business Wire)

Butterfly Network Expands its Next-Generation Butterfly iQ3™ to Europe

INSIGHTEC ANNOUNCES EXABLATE PRIME AVAILABILITY IN EUROPE -THE NEXT GENERATION OF MR-GUIDED FOCUSED ULTRASOUND

PR Newswire associated0

Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us